alexa Pilot Study of the Estimation of Amphetamines Consumption in the Polish City of Poznan | Open Access Journals
ISSN: 2157-7145
Journal of Forensic Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Pilot Study of the Estimation of Amphetamines Consumption in the Polish City of Poznan

Jolanta Klos*, Piotr Nowicki and Zenon Kokot

Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Poland

*Corresponding Author:
Jolanta Klos
Poznan University of Medical Sciences
Faculty of Pharmacy
Department of Inorganic and Analytical Chemistry
6 Grunwaldzka Street, 60-780 Poznan, Poland
Tel: +48 618546618
Fax: +48 8546609
E-mail: [email protected]

Received date: October 02, 2013; Accepted date: October 29, 2013; Published date: October 31, 2013

Citation: Klos J, Nowicki P, Kokot Z (2013) Pilot Study of the Estimation of Amphetamines Consumption in the Polish City of Poznan. J Forensic Res 4:203. doi: 10.4172/2157-7145.1000203

Copyright: © 2013 Klos J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Forensic Research

Abstract

According to the European Monitoring Centre for Drugs and Drug Addiction Annual Report 2011 in many European countries amphetamines or ecstasy is the second most commonly used illicit substance after cannabis. More reliable and objective method based on the ‘sewage epidemiology’ was applied to estimate the level of amphetamines consumption in Poland. Amphetamine, methamphetamine and MDMA (ecstasy) were determined in wastewater samples collected from the main Wastewater Treatment Plant in the Polish city of Poznan (about 687,000 people) using liquid chromatography/tandem mass spectrometry (LC-MS-MS). Back-calculations used in the ‘sewage epidemiology’ approach were applied to estimate the level of consumption of analyzed drugs. Analysis of variance (ANOVA) was applied to check the monthly differences between determinations. Two-year profiles of consumption for amphetamine methamphetamine and ecstasy were calculated. Results from our city indicate that consumption of amphetamines is one order of magnitude lower than in Western Europe. Therefore, there is a different profile of amphetamines consumption. Consumption of amphetamine is several times lower, but the consumption of ecstasy is relatively high. ANOVA analysis confirmed significant differences between monthly loads of determined illicit drugs

Keywords

Drug abuse; Amphetamines; Wastewater treatment plants; Amphetamines consumption

Introduction

Amphetamines are a term that includes both amphetamine and methamphetamine, both of which stimulate the central nervous system. Ecstasy is a group of synthetic substances chemically related to amphetamines but with some differences in their effects. The most common substance belonging to the ecstasy group is 3, 4-methylenedioxymethamphetamine (MDMA), but other analogues are also sometimes found in ecstasy tablets (MDA, MDEA). Illicit amphetamine use is associated with a broader set of negative consequences, such as shortterm negative effects (restlessness, tremor, anxiety, dizziness), a ‘crash’ or coming-down after-effect (depression, sleeping difficulties, suicidal behavior), and also psychological and psychiatric effects of long-term use (psychosis, suicidal behavior, anxiety and violent behavior) [1].

The United Nations Office on Drugs and Crime (UNODC 2011) reported that in 2009-2010 4.5% of the world’s population aged 15-64 used cannabis, 1.3% used amphetamines, 0.6% Ecstasy-group stimulants and cocaine 0.5% [2]. According to the European Monitoring Centre for Drugs and Drug Addiction Annual Report 2011, in many European countries amphetamines or ecstasy are the second most commonly used illicit substances after cannabis. Significant methamphetamine use is restricted to the Czech Republic and Slovakia (our neighbors) but recent reports indicate an increase in amphetamine use in some countries in northern Europe [3]. Based on surveys conducted in Poland in 2008, cannabis and amphetamines are the most commonly used illicit drugs [4].

The official figures on the prevalence of drug abuse are currently derived from population surveys integrated with crime statistics, medical records, drug production and seizure rates. Such estimation is subjective and very expensive. In 2005, the Zuccato group estimated the level of consumption of cocaine based on the determination of cocaine and their metabolite in surface water and wastewater [5]. This methodology appeared to be much more relevant and objective. Nevertheless, the procedure needs to be standardized to make comparison of results in many countries more reliable, but the methodology gives an objective insight into the level and profile of illicit drugs consumed by local community in real time. Recently, many reports concerning the estimation of illicit drug abuse using ‘sewage epidemiology’ have been published in many European countries, such as Belgium [6-8], United Kingdom [9], Italy - Florence [10], Spain [11-13], Croatia [14], Switzerland [15] and also in Canada [16] and the United States of America [17-19].

According to surveys conducted in Poland amphetamine is a commonly used illicit drug, and this is why the group of amphetamine-like stimulants was chosen for analysis (amphetamine, methamphetamine, MDA, MDMA, MDEA) [4]. The aims of this study were to implement ‘sewage epidemiology’ to estimate the level of amphetamines consumed in Poland’s fifth largest city, Poznan, describe the profile of amphetamines used and monitor the long-term trends in amphetamines use.

Materials and Methods

Wastewater treatment plant in poznan

The Wastewater Treatment Plant is located in north-east of Poznan, in the township of Kozieglowy. The facilities are located on the right bank of the Warta river and occupies an area of approximately 60 hectares. The central wastewater treatment plant has undergone several modifications to meet present demands from the year 1995 to 2009. The new and highly efficient biological section was constructed, which incorporates a system enabling the integrated biological removal of carbon, nitrogen and phosphorus. The capacity of the plant is one of the largest of such facilities of Poland. During the time when samples were collected the central plant served almost the whole city with the suburbs, about 687,000 people.

Standards and reagents

All pure standards: amphetamine, methamphetamine, 3, 4-methylenedioxyamphetamine (MDA), 3, 4-methylenedioxymethamphetamine (MDMA or ecstasy), 3, 4-methylenedioxyethylamphetamine (MDEA) and their deutered molecules used as internal standards: amphetamine–d6, methamphetamine-d9, MDA-d5, MDEA-d5 and MDMA- d5 were purchased from Certilliant, a Sigma-Aldrich’ Company. The standards-solutions in methanol (1 mg/mL)-were diluted to 10 ng/ μL with methanol and stored at -20°C in the dark. All other reagents were acquired from J.T. Beker (USA).

Sample collection and processing

Two wastewater samples (10 L each) were collected twice a week, on Monday and on Wednesday, from June 2009 to December 2010. All samples were collected at the same point before any chemical and physical treatment with the exception of sedimentation and the mean flow rate was 130,000 m3/day. The analyses of the samples were performed the same day just after collection.

Sample treatment and analysis

Samples were filtered on a glass microfiber filter GF/A 1.6 μm (Whatman, Kent, U.K.) prior to the extraction and were spiked with 15 ng of each internal standards and the pH was adjusted to 7.0 ± 0.4 with phosphate buffer (pH=7.0). Solid-phase extraction of analyzed substances was performed using a Bakerbond Narc-2 mixed mode cartridges, which were conditioned with methanol (2 mL) followed by deionized water (2 mL) followed by phosphate buffer (2 mL, 0.1 M, pH 7.0). Next the sample was passed through the cartridges under vacuum at a flow rate of 10 mL/min. When the sample eluted under the gravity, the column was washed with deionized water (2 mL) followed by hydrochloric acid (0.1 M, 0.5 mL) followed by methanol (0.5 mL). Vacuum was applied and the cartridges were dried for 20-30 min. The analytes were eluted into a vial with a mixture of chloroform: isopropanol: ammonium hydroxide (80:30:3, 2 mL). The eluates of two samples (each 10 L) were pooled and dried under a nitrogen stream.

Liquid chromatography-tandem mass spectrometry

Pooled and dried samples were redisolved in 200 μL of mobile phase, centrifuged and transferred into glass vials for instrumental analysis. 20 μL of the solution were injected in the LC-MS spectrometer (Agilent HPLC 1200 series, 6410B Triple Quad LC/MS System). Chromatographic separation was performed using capillary column (Agilent Zorbax XDBC18, 4.6×50 mm×1.8 μm) at a flow rate of 0.45 mL/min. The mobile phases were solutions: water with formic buffer (pH~3.2) and acetonitrile with the gradient from 10 to 70% of acetonitrile (6.5 min.). The capillary voltage was 4000 V and the temperature was 300°C, the auxiliary and collision gas was N2. The collision energy and tube lens were optimized for each analyte and standards separately. All selected analytes were analyzed in positive ionization mode (ESI+). Identification and quantification were performed using two characteristic transitions in multiple reaction monitoring (MRM) mode for the fragmentation products of the protonated or deprotonated pseudomolecular ions of each substance and each deutered analogue (Table 1).

Substance Retention time (min) Fragmentor Voltage Precursor ion m/z Product ion I m/z and collision energy (eV) Product ion II m/z and collision energy (eV)
Amphetamine-D6 3.4 60 142.1 125.1 (8) 93.1 (17)
Amphetamine 3.4 70 136 119.1 (5) 91.1 (17)
MDA-D5 3.6 70 185.1 168.1 (5) 110.1 (21)
MDA 3.6 60 180.1 163 (5) 105.1 (21)
Methamphetamine-D9 3.8 80 159.2 125.1 (5) 93.05 (17)
Methamfetamina 3.8 80 150.1 119.1 (8) 91 (17)
MDMA-D5 3.9 80 199.1 165 (9) 107.1 (25)
MDMA 3.9 80 194.1 163.1 (5) 105.1 (25)

Table 1: Conditions for MRM determination of illicit drugs.

8-point calibration curve was built at 4, 8, 12, 16, 20, 24, 28, 32 ng for amphetamine, methamphetamine, MDA and MDMA and the solutions were spiked with 30 ng of all internal standards. Validation was done according to Funk methodology, including testing homogeneity, linearity, homogeneity of variances (precision), outliers and securing the lower range limit [20,21]. The matrix effect was determined by analyzing 50 mL of wastewater samples spiked with internal standards. The recoveries for the whole process of sample preparation, filtration and extraction were set within the range 0.80-0.93. The detection limits (LOD) and quantification limits (LOQ) for the whole method were calculated by spiking wastewater samples with different amounts of the substances analogously like at the calibration curve. The results all of validation activities are shown in Table 2.

Substance y=bx+a Residual standard deviation Process standard deviation Processvariation coefficient (%) Decision limit DL (ng/L) Detection Limit LOD (ng/L) Quantification limit LOQ (ng/L)
a b
(DIN 32645)
Amphetamine 531 1270 2.57 0.20 1.12 0.36 0.71 1.07
Range 1-2.4
Methamphetamine 15555 126.7 6.96 0.55 3.06 0.81 1.65 2.32
Range 3.5-7
MDMA 40.28 1143 6.09 1.11 6.09 0.89 1.77 2.66
Range 3-4.8

Table 2: Validation according to Funk (German Standard DIN 32645).

Back-calculation of community drug use

The first time back-calculation of illicit drug consumption was carried out was by Zuccato et al. [5,19,20]. Based on the determination of the major metabolite of cocaine (benzoylecgonine, BE) in wastewater and surface water, cocaine consumption in a few Italian cities was estimated. This approach has been developed for other illicit drugs. For each drug the substance, called drug target residues (DTRs), is specified. An ideal DTR is a major and exclusive excretion product, metabolite or unchanged parent drug, which is stable in wastewater. Amphetamines are excreted mainly as unchanged compounds, so the DTRs for them were parent drugs. The concentrations of these substances in wastewater samples were very low and therefore the dried residues of two untreated wastewater samples (each 10 L) after filtration and SPE extraction were pooled and joined together by redissolving in the mobile phase to perform HPLC-MS-MS analysis. The mean concentrations of DTR in ng/L of all samples collected in one month were multiplied by the monthly mean flow rate in the wastewater treatment plant (WWTP) to give the amount of DTR (grams) discharged per month. This value was then divided by the number of people served by the WWTP to estimate the grams of DTR excreted in wastewater per person per month and finally normalized to a value of grams per month per 1000 people. To estimate the consumption of the illicit drug a correction factor is applied, which takes into account the percentage of the parent drug excreted as the chosen DTR and the parent drug-to-DTR molar mass ratio. The correction factors for amphetamines were 3.3, 2.3 and 1.5 for amphetamine, methamphetamine and ecstasy respectively. As a result, the amount of illicit drugs consumed monthly by 1000 people was estimated.

It is also possible to estimate the number of doses consumed by local community (1000 people) per day or month by dividing the consumption value by a single typical dose for each illicit drug. A typical oral dose for amphetamine and methamphetamine is 30 mg, but for MDMA (ecstasy) it is 100 mg. But it is recommended to focus on the loads of illicit drugs estimated for 1000 people per day or loads of DTR excreted per day per 1000 people and these results should be monitored for a period of time to give an objective insight into the level and profile of illicit drugs consumed by local community.

Statistical analysis

Graphical method and Shapiro Wilk test were used for testing the normal distribution of samples. To check whether the mean value of determinations in one month differs from mean in another the analysis of variance-one-way ANOVA- was performed (Matlab v. 7120635). The null hypothesis assumed the all monthly means of determinations are equal. It was interested not only if there are any differences among means but even more important which pairs of means differ significantly, that is why series of t-tests were performed. Because this procedure has a pitfall when you compare more than five variables (means) multiple comparison procedure was applied to compensate for multiple tests. It is easier to visualize the difference between monthly means using a graph which is presented in Figure 1. The procedure applied for the collection of samples and determination of illicit substances did not allow daily variations in the drugs consumed to be compared.

forensic-research-Multiple-Comparisons-Visualization

Figure 1: (A) Amphetamine. (B) Methamphetamine. (C) MDMA (ecstasy). Multiple Comparisons. Visualization of the difference between group means (DTR loads/mg/month/1000 people). Triangle in the vertical line-no significant difference, circle-significant difference.

Results and Discussion

The results of determination of amphetamine, methamphetamine and ecstasy in wastewater samples are collected in Table 3. The normal distribution of variables was checked by graphical method and Shapiro-Wilks test (p>0.05). Based on the determination of DTR in wastewater samples population-standardized mean monthly loads of DTR were calculated. To check an increasing or decreasing tendency between months one way ANOVA and Multiple Comparison Test were applied. The results of ANOVA are presented in Table 4. Based on the F and p-values the null hypothesis was rejected. P-values are very below the cut-off level of 0.05% therefore it can be stated that the differences between monthly means are very high significant. The Multiple Comparison Test visualized the results and showed significant differences between means of monthly DTR loads (mg/month/1000 people) except: February-July-September 2010 and June 2009-March 2010 in case of amphetamine; April-September 2010 and August- December 2009 in case of methamphetamine (Figure 1).

Month Concentration (ng L-1) DTR massloads mg/month/1000ppl Drug consumption mg/month/1000ppl Number of doses dose/month/1000ppl
AMF (±0.03) MET (±0.07) MDMA (±0.07) AMF (±0.03) MET (±0.07) MDMA (±0.07) AMF (±0.03) MET (±0.07) MDMA (±0.07) AMF (±0.03) MET (±0.07) MDMA (±0.07)
Jun’09 0.25 1.22 1.56 1.99 9.42 12.12 6.573 21.66 18.18 0.22 0.72 0.14
Jul’09 0.32 1.35 1.54 2.64 10.78 12.64 8.70 24.78 18.96 0.29 0.82 0.14
Aug’09 0.40 1.46 1.29 2.84 10.42 9.21 9.37 23.98 13.82 0.31 0.80 0.10
Sep’09 0.34 1.38 1.38 2.27 9.30 9.27 7.49 21.40 13.91 0.25 0.71 0.10
Oct’09 0.30 1.37 1.39 2.18 9.83 10.04 7.22 22.61 15.06 0.24 0.75 0.11
Nov’09 0.30 1.26 1.82 2.18 8.84 12.61 7.22 20.34 18.92 0.24 0.68 0.14
Dec’09 0.48 1.41 1.71 3.64 10.76 13.00 12.02 24.76 19.50 0.40 0.82 0.15
Jan’10 0.34 1.41 2.03 1.78 7.42 10.69 5.89 17.06 16.04 0.19 0.57 0.12
Feb’10 0.25 1.37 1.92 1.24 6.70 9.39 4.09 15.40 14.08 0.14 0.51 0.11
Mar’10 0.27 1.03 1.83 1.97 7.56 13.44 6.52 17.38 20.16 0.22 0.58 0.15
Apr’10 0.29 0.96 1.83 1.63 5.38 10.21 5.40 12.38 15.31 0.19 0.41 0.12
May’10 0.59 0.81 1.82 3.68 5.08 11.39 12.13 11.68 17.01 0.40 0.39 0.13
Jun’10 0.69 0.83 1.75 3.22 3.90 8.20 10.63 8.97 12.31 0.35 0.30 0.09
Jul’10 0.25 0.69 1.14 1.32 3.60 5.97 4.38 8.28 8.96 0.15 0.27 0.07
Aug’10 0.24 0.66 1.12 1.43 3.99 6.72 4.73 9.19 10.08 0.16 0.31 0.08
Sept’10 0.23 0.76 1.27 1.32 4.30 7.14 4.36 9.89 10.71 0.14 0.33 0.08
Oct’10 0.48 1.24 1.17 2.43 6.24 5.90 8.02 14.36 8.85 0.27 0.48 0.06
Nov’10 0.64 0.87 1.29 3.97 5.41 8.02 13.11 12.44 12.02 0.44 0.41 0.09
Dec’10 0.71 0.91 1.02 4.34 5.58 6.27 14.32 12.83 9.41 0.47 0.43 0.07

Table 3: Results of determination of amphetamine, methamphetamine and MDMA (ecstasy) from June 2009 to December 2010.

  Sums of Squares (SS) Degree of Freedom (dF) Mean Squares (SS/df) (MS) F-statistic Prob>F (p)
  Amphetamine
Columns 65.9156 18 3.66198 13902.48 5.24361e-097
Error 0.015 57 0.00026    
Total 65.9307 75      
  Methamphetamine
Columns 449.216 18 24.9564 106918.78 2.97059e-122
Error 0.013 57 0.0002    
Total 449.229 75      
  MDMA
Columns 452.88 18 25.16 187006.79 3.57393e-129
Error 0.008 57 0.0001    
Total 452.887 75      

Table 4: Results of ANOVA analysis.

Processing of DTR extraction data allowed us to calculate the consumption rate (mg/month/1000 inhabitants) for the amphetamines group substances (in our case amphetamine, methamphetamine and ecstasy) as described in the section named “Materials and methods” (Figure 2). Because of the low limit of DTRs in wastewater, significantly more samples were subjected to analysis. Comparison of drug consumption with other reports [19,11,14] by other Western European scientists using a similar methodology shows significant differences in consumption amounts and the profiles of amphetamine-group substances (Table 5). Generally speaking, consumption of amphetamines is one order of magnitude lower than in the countries compared. The mean drug consumption of amphetamine amounts to 0.33% (incase of London) to 2.9% (in case of Milan) of overall drug consumption. In case of ecstasy and methamphetamine, the percentage range is 5.30- 13.25% (in case of Catalonia even 0.24%) and 5.1-9.67% respectively. Because drug consumption is standardized per day and per thousand people, these results seem to be comparable. An interesting fact is that cocaine was detected only once during the two-year study period. It is important to remember that these data were collected in different time periods (a few weeks monitoring was compared with a continuous two-year study) but in the authors’ opinion, for general comparison purposes this approach is justified. The choice of city where our studies were carried out resulted from the author’s place of residence and work, and also poll based data not indicating that Poznan is a city with special addiction problem. Therefore, it is possible that monitoring in other cities might give different results. The official Polish statistics do not offer any integrated data on the consumption of different types of illicit drugs in Poznan and other Polish cities. Official data are based on the number of people treated and hospitalized. Our calculations indicate that amphetamine consumption in Poznan (mean 0.26 mg/day/1000 inh.) is several times lower than in Western Europe (Table 5) and slight lower compared to London. Consumption of ecstasy is relatively high, but still makes up 13.25% at the most. An interesting fact is that the amphetamine to ecstasy consumption rate in case of Poznan is 0.55, while it is 2.7, 1.4, and 7.6 for Zagreb, Milan and Catalonia respectively. This indicates a different profile of consumption and a different ‘liking for illicit drug’ among Poznan’s inhabitants. In London and Milan, the data show a higher level of methamphetamine consumption compared to Poznan. At this point it is important to take into consideration the sample collection and processing, which can be distinguished from other authors with regard to the amount of samples prepared and analyzed. Using a 20 L sample for analysis made this more complicated (because of the matrix effect) and more laborious, but it did make it possible to detect traces in wastewater. When interpreting the comparison of consumption in Poznan and other cites, it is important to note that this comparison concerns only those cities where the concentration of amphetamine-type drugs was especially high. In other cites which were monitored, where the authors did not give figures for amphetamine consumption, it was under the detection or quantification limit using a 0.5 L sample. It is possible that in these cities the level of consumption is comparable with Poznan. It is therefore worth noting that the low level of consumption in Poznan compared with other cites may result from the selection of cities.

forensic-research-Mean-monthly-consumption

Figure 2: Mean monthly consumption (mg/month/1000 people) of amphetamine (AMF), methamphetamine (MET) and MDMA (ecstasy) from June 2009 to December 2010.

City/Area (Country) Consumptionunits Amphetamine Ecstasy Methamphetamine References
Zagreb (Croatia) mg/day/1000 ihb. 9.7 3.6   Terzic et al. [14]
Milan (Italy) mg/day/1000 ihb. 8.9 8.9 10.35 Zuccato et al. [19]
London (UK) mg/day/1000 ihb. 79 5.1 5.52 Zuccato et al. [20]
Poznan (Poland) mg/day/1000 ihb. 0.26 0.47 0.53 This study
Lugano (Switzerland) mg/day/1000 ihb. - 10.9   Zuccato et al. [20]
Catalonia (Spain) mg/day/1000 ihb. - 200   Boleda et al. [11]

Table 5: Amphetamines-group substances consumption. Comparison with previously published date for Western Europe region.

In our study an attempt was made not only to estimate the number of mg of consumed illicit drugs by local population but to indicate trends in consumption. To achieve this aim, the authors changed the way of collecting samples compared with others research (see Sample collection and processing). The data obtained allowed us to generate two-year profiles of consumption for amphetamine methamphetamine and ecstasy (Figure 2). The profile indicates a gentle decrease in the monthly consumption of amphetamine in Poznan from May 2010 to the end of the monitoring period. It is difficult to make a comparison with other works because there are no such long-term monitoring data and these data would need to be compared over the same period of time.

Conclusion

Wastewater analysis and monitoring of illicit drug content and calculation of consumption is a promising complementary tool for the assessment of trends in illicit drug abuse. Our research was the first of its kind carried out in Poland. The monitoring focused particularly on the amphetamine group. Consumption of amphetamine is lower than in other compared European countries, but consumption of ecstasy is relatively high. The profile of consumption of drug abuse substances is different in city of Poznan.

Acknowledgements

This study was supported by Polish Ministry of Science and Higher Education and National Bureau for Drug Prevention. The authors are grateful to the staff of the central wastewater treatment plant of the city of Poznan in Kozieglowy for helping with wastewater sampling and providing data on influent flow rates.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 11763
  • [From(publication date):
    November-2013 - Oct 21, 2017]
  • Breakdown by view type
  • HTML page views : 7984
  • PDF downloads :3779
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords